In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Device/Diagnostics Quarterly Deal Statistics, Q3 2012

Executive Summary

Device companies raised a total of $801 million in 2012’s third quarter, an 18% drop from Q2’s $977 million. Approximately $2.6 billion was spent on device acquisitions, exactly $2 billion less than Q2’s total. Diagnostic/research company financings totaled $484 million during Q3 2012, up from last quarter’s $336 million. And while diagnostic/research M&A activity was not as prolific as last quarter, tech transfer deals are seeing a resurgence.

Advertisement

Related Content

Option-To-Acquire In Medical Device Deals Rarely Gets Exercised
Could Medtronic’s Kanghui Purchase Set Course For US Entry?
Danaher Expands Diagnostics Offerings Via $338 Mil. IRIS Acquisition
In Cartilage Repair Histogenics Resets The Stage
Teleflex To Dominate Laryngeal Mask Market Following $276 Mil. LMA Buy
Thermo Fisher To Dominate Transplant Dx Market With $925 Million One Lambda Purchase
Smaller Players Find Opportunity In Large Joints
Percutaneous Mitral Valve Therapy: The Next Decade

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV003787

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel